Liquidia Technologies, Inc. (LQDA) Social Stream
Featured Post From StockTwits About LQDA
$LQDA Why would UTHR mention LQDA in the earnings call?SeedF, published August 6, 2020
United Therapeutics files amended patent infringement complaint on Liquidia United Therapeutics (UTHR) announced the United States Patent and Trademark Office issued a new patent on relating to Tyvaso Inhalation Solution. The new patent, U.S. Patent No. 10,716,793, expires May 14, 2027, and is listed in the FDA's Approved Drug Products with Therapeutic Equivalence Evaluations publication, also known as the Orange Book, for Tyvaso. Yesterday, United Therapeutics filed an amended complaint against Liquidia Technologies (LQDA) in its pending patent infringement litigation in the U.S. District Court for the District of Delaware to include a claim for infringement of this new patent.